Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate postoperative events in patients noted to have retained nuclear fragments in the anterior vitreous during routine phacoemulsification and in those who did not.
In this study, we investigate whether presence of retained nuclear fragments in the anterior vitreous noted during uncomplicated cataract surgery is associated with higher incidence of postoperative adverse events. We will be assessing events including cystoid macular edema, iritis, elevated intraocular pressure, and retinal detachment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cataract Phacoemulsification | Subjects will be recruited serially from eligible candidates on the basis of presentation for cataract evaluation and subsequent cataract surgery with phacoemulsification. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Phacoemulsification | Procedure | Subjects will be recruited serially from eligible candidates on the basis of presentation for cataract evaluation and subsequent cataract surgery with phacoemulsification. |
| Measure | Description | Time Frame |
|---|---|---|
| Macular edema | Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 1 month postoperatively | 1 month postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Intraocular inflammation | Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 1 month postoperatively | 1 month postoperativley |
| Elevated intraocular pressure |
| Measure | Description | Time Frame |
|---|---|---|
| Surgical Complications | Proportion of eyes with surgical adverse events. | Intraoperatively |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects will be recruited serially from eligible candidates on the basis of presentation for cataract evaluation and subsequent cataract surgery with phacoemulsification.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Ritterband, MD | Ophthalmic Consultants, Cornea and Refractive Surgery Assoicates, PC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ophthalmic Consultants, Corneal and Refractive Surgery Associates, PC | New York | New York | 10003 | United States |
Not provided
| ID | Term |
|---|---|
| D002386 | Cataract |
| ID | Term |
|---|---|
| D007905 | Lens Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D018918 | Phacoemulsification |
| ID | Term |
|---|---|
| D002387 | Cataract Extraction |
| D054140 | Refractive Surgical Procedures |
| D013508 | Ophthalmologic Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Proportion of eyes with intraocular pressure increase requiring medical or surgery treatment at 1 month postoperatively
| 1 month postoperatively |
| Macular Edema | Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 1 week postoperatively | 1 week postoperatively |
| Intraocular Inflammation | Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 1 week postoperatively | 1 week postoperatively |
| Elevated Intraocular Pressure | Proportion of eyes with intraocular pressure increase requiring medical or surgery treatment at 1 week postoperatively | 1 week postoperatively |
| Macular Edema | Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 3 months postoperatively | 3 months postoperatively |
| Intraocular Inflammation | Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 3 months postoperatively | 3 months |
| D059708 | Ultrasonic Surgical Procedures |